Is pombilitiopfoldahcp.com Safe? Security Analysis for Amicus Therapeutics US, LLC
https://pombilitiopfoldahcp.comCheck if pombilitiopfoldahcp.com is a scam or legitimate. Free security scan and reviews.
Above Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for pombilitiopfoldahcp.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
The website for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) is a professionally designed healthcare professional portal operated by Amicus Therapeutics US, LLC. It provides comprehensive clinical data, dosing information, safety warnings, and patient support resources for a specialized pharmaceutical therapy targeting late-onset Pompe disease. The site is clearly targeted at US healthcare professionals and includes links to official prescribing information and patient referral forms. The domain is relatively new, registered in 2022, consistent with the product's market introduction timeline. Technically, the website employs modern tracking and analytics tools such as Google Tag Manager and Microsoft Clarity, alongside a cookie consent mechanism powered by OneTrust, indicating a moderate level of digital maturity and privacy awareness. The site is mobile-optimized, accessible, and SEO-friendly, with a consistent branding approach aligned with the parent company Amicus Therapeutics. Hosting and DNS services are stable, though DNSSEC is not enabled, representing a minor security gap. From a security perspective, the site uses HTTPS and includes cookie consent banners, but lacks explicit security policies or vulnerability disclosure pages. No critical vulnerabilities or exposed sensitive data were detected. The WHOIS data shows domain registration with protections against unauthorized transfer or deletion, supporting legitimacy. Overall, the site demonstrates a solid security posture with room for improvement in DNS security and transparency around incident response. The overall risk assessment is low, with the site serving as a trustworthy source of pharmaceutical information for healthcare professionals. Strategic recommendations include enabling DNSSEC, publishing a security policy or vulnerability disclosure page, and enhancing security headers to further strengthen the security posture.
Detected Technologies
7 urgent findings need attention
1 critical · 6 high
Keep pombilitiopfoldahcp.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
4 findings
65/100
GDPR Compliance
1 finding
88/100
NIS2 Compliance
8 findings
17/100
Email Security
5 findings
60/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Amicus Therapeutics operates this site as part of its pharmaceutical business focused on rare diseases, specifically late-onset Pompe disease. The site supports the business model of providing healthcare professionals with detailed product information, clinical trial data, and patient support tools to facilitate treatment adoption. The company leverages partnerships and related domains to segment audiences between healthcare professionals and patients. The presence of official prescribing information and boxed warnings indicates regulatory compliance and market positioning as a specialized rare disease therapy provider. The business targets US healthcare professionals, indicating a focused market segment. The domain age and registration details align with a relatively recent product launch, supporting growth and market entry strategies. The company maintains a consistent brand presence and uses digital marketing and analytics tools to monitor engagement and optimize outreach.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate to good security posture with HTTPS enforced and cookie consent implemented. The domain registration includes clientDeleteProhibited and clientTransferProhibited statuses, which protect against unauthorized domain changes. However, DNSSEC is not enabled, which is a recommended best practice to prevent DNS spoofing. No explicit security.txt or vulnerability disclosure pages were found, limiting transparency for security researchers. Security headers are not explicitly visible in the HTML but may be present at the server level. No exposed sensitive data or vulnerable libraries were detected in the page source. The use of third-party analytics and tracking scripts is balanced with consent mechanisms, supporting privacy compliance. Incident response contact information is not provided, which could be improved to enhance security readiness. Overall, the site is secure for its purpose but could benefit from additional security transparency and DNS hardening.
Strategic Recommendations
Priority Actions for Security Improvement
Enable DNSSEC on the domain to improve DNS security and prevent spoofing attacks.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Amicus Therapeutics US, LLC
Official healthcare professional site providing information about POMBILITI and OPFOLDA, a two-component therapy for adults with late-onset Pompe disease. Includes clinical data, dosing, safety information, and support resources.
good
consistent
Technical Stack
moderate
good
good
good
Security Assessment
- HTTPS enforced
- Cookie consent implemented
- No exposed sensitive data in HTML
- Use of security-focused scripts
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is a professional healthcare product site for POMBILITI and OPFOLDA by Amicus Therapeutics.
Get this report delivered to your inbox
Receive a summary of the pombilitiopfoldahcp.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Weak Strict-Transport-Security configuration
LOWCurrent value: "max-age= 15768000; includeSubDomains; preload"
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Need this report as a PDF?
Download the complete pombilitiopfoldahcp.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No DKIM record found
MEDIUMDKIM adds cryptographic signatures to emails
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
No email authentication configured
CRITICALDomain is vulnerable to email spoofing
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 32 days
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does pombilitiopfoldahcp.com compare?
See how pombilitiopfoldahcp.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the pombilitiopfoldahcp.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the pombilitiopfoldahcp.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about pombilitiopfoldahcp.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published